BridgeMD
Tests treatment safety and results for Huntington Disease
Official title Safety and Tolerability Study of Human Neural Stem Cells for Huntington's Disease
ClinicalTrials.gov ID: NCT07451613
What this study is testing
What is hNSC-01?
hNSC-01 is an investigational medicine, being studied as a potential treatment for huntington disease.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this research study is to determine whether an implantation of hNSC-01 is a safe and tolerable study intervention for Huntington's disease. This study is the first time that hNSC-01 is being tested in people.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Please note this may not be a complete list of eligibility criteria.
- Have decision-making capacity and be able to provide written informed consent.
- Are between 18 to 65 years of age
- Have genetically confirmed diagnosis of Huntington's Disease
- Able to undergo MRI scans, tolerate neurosurgical procedure, blood draws and lumbar puncture.
You likely can't join if
- Are pregnant
- Test positive for human immunodeficiency virus (HIV), hepatitis C or chronic hepatitis B at Screening
- Have an implanted deep brain stimulation device.
The study team makes the final eligibility decision.
Where it's taking place
- Irvine, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Irvine, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.